NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Compare Bioavailability of RO7239361 After Subcutaneous Injection

CompletedPhase 1

Sponsor: Hoffmann-La Roche

Conditions: Healthy

Interventions: RO7239361

Countries: United States

Randomized study in healthy men and women. Assess the similarity of RO7239361 when injected into the arm, thigh, or the stomach. Collect data on safety of RO7239361.

Eligibility overview

Sex: ALL

Age: 18 Years to 55 Years

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Healthy participant as determined by no significant deviations in normal medical and surgical history and assessments
* Body Mass Index 18 kg/m2 to 32 kg/m2
* females must be of non-childbearing potential

Exclusion Criteria:

* tattoos or other skin findings on any of the potential injection sites
* history of chronic muscle pain within 30 days prior to study treatment
* prior history of IgG1 therapy

Other protocol defined inclusion and exclusion criteria apply

Locations (1)

Cypress, California, United States